|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2020. CA Cancer J Clin. 70:7–30. 2020.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Zhang L, Sanagapalli S and Stoita A:
Challenges in diagnosis of pancreatic cancer. World J
Gastroenterol. 24:2047–2060. 2018.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Chu LC, Goggins MG and Fishman EK:
Diagnosis and detection of pancreatic cancer. Cancer J. 23:333–342.
2017.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Miller KD, Nogueira L, Mariotto AB,
Rowland JH, Yabroff KR, Alfano CM, Jemal A, Kramer JL and Siegel
RL: Cancer treatment and survivorship statistics, 2019. CA Cancer J
Clin. 69:363–385. 2019.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Dowling DP, Di Costanzo L, Gennadios HA
and Christianson DW: Evolution of the arginase fold and functional
diversity. Cell Mol Life Sci. 65:2039–2055. 2008.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Carvajal N, López V, Salas M, Uribe E,
Herrera P and Cerpa J: Manganese is essential for catalytic
activity of Escherichia coli agmatinase. Biochem Biophys Res
Commun. 258:808–811. 1999.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Uribe E, Reyes MB, Martinez I, Mella K,
Salas M, Tarifeño-Saldivia E, López V, García-Robles M,
Martínez-Oyanedel J, Figueroa M, et al: Functional analysis of the
Mn2+ requirement in the catalysis of ureohydrolases
arginase and agmatinase-a historical perspective. J Inorg Biochem.
202(110812)2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Li G, Regunathan S, Barrow CJ, Eshraghi J,
Cooper R and Reis DJ: Agmatine: An endogenous clonidine-displacing
substance in the brain. Science. 263:966–969. 1994.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Su CH, Liu IM, Chung HH and Cheng JT:
Activation of I2-imidazoline receptors by agmatine improved insulin
sensitivity through two mechanisms in type-2 diabetic rats.
Neurosci Lett. 457:125–128. 2009.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Satriano J, Cunard R, Peterson OW, Dousa
T, Gabbai FB and Blantz RC: Effects on kidney filtration rate by
agmatine requires activation of ryanodine channels for nitric oxide
generation. Am J Physiol Renal Physiol. 294:F795–F800.
2008.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Penner SB and Smyth DD: Natriuresis
following central and peripheral administration of agmatine in the
rat. Pharmacology. 53:160–169. 1996.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Cunha AS, Matheus FC, Moretti M, Sampaio
TB, Poli A, Santos DB, Colle D, Cunha MP, Blum-Silva CH, Sandjo LP,
et al: Agmatine attenuates reserpine-induced oral dyskinesia in
mice: Role of oxidative stress, nitric oxide and glutamate NMDA
receptors. Behav Brain Res. 312:64–76. 2016.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Lee WT, Hong S, Yoon SH, Kim JH, Park KA,
Seong GJ and Lee JE: Neuroprotective effects of agmatine on
oxygen-glucose deprived primary-cultured astrocytes and nuclear
translocation of nuclear factor-kappa B. Brain Res. 1281:64–70.
2009.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Moretti M, Matheus FC, de Oliveira PA,
Neis VB, Ben J, Walz R, Rodrigues AL and Prediger RD: Role of
agmatine in neurodegenerative diseases and epilepsy. Front Biosci
(Elite Ed). 6:341–359. 2014.PubMed/NCBI View
Article : Google Scholar
|
|
15
|
Mistry SK, Burwell TJ, Chambers RM,
Rudolph-Owen L, Spaltmann F, Cook WJ and Morris SM Jr: Cloning of
human agmatinase. An alternate path for polyamine synthesis induced
in liver by hepatitis B virus. Am J Physiol Gastrointest Liver
Physiol. 282:G375–G381. 2002.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Snezhkina AV, Krasnov GS, Lipatova AV,
Sadritdinova AF, Kardymon OL, Fedorova MS, Melnikova NV, Stepanov
OA, Zaretsky AR, Kaprin AD, et al: The dysregulation of polyamine
metabolism in colorectal cancer is associated with overexpression
of c-Myc and C/EBPβ rather than enterotoxigenic bacteroides
fragilis infection. Oxid Med Cell Longev.
2016(2353560)2016.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Zhu HE, Yin JY, Chen DX, He S and Chen H:
Agmatinase promotes the lung adenocarcinoma tumorigenesis by
activating the NO-MAPKs-PI3K/Akt pathway. Cell Death Dis.
10(854)2019.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408.
2001.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Tsai JH and Yang J: Epithelial-mesenchymal
plasticity in carcinoma metastasis. Genes Dev. 27:2192–2206.
2013.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Xu J, Lamouille S and Derynck R:
TGF-beta-induced epithelial to mesenchymal transition. Cell Res.
19:156–172. 2009.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Lengyel E, Schmalfeldt B, Konik E, Späthe
K, Härting K, Fenn A, Berger U, Fridman R, Schmitt M, Prechtel D
and Kuhn W: Expression of latent matrix metalloproteinase 9 (MMP-9)
predicts survival in advanced ovarian cancer. Gynecol Oncol.
82:291–298. 2001.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Roomi MW, Monterrey JC, Kalinovsky T, Rath
M and Niedzwiecki A: In vitro modulation of MMP-2 and MMP-9
in human cervical and ovarian cancer cell lines by cytokines,
inducers and inhibitors. Oncol Rep. 23:605–614. 2010.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Peinado H, Quintanilla M and Cano A:
Transforming growth factor beta-1 induces snail transcription
factor in epithelial cell lines: Mechanisms for epithelial
mesenchymal transitions. J Biol Chem. 278:21113–21123.
2003.PubMed/NCBI View Article : Google Scholar
|
|
24
|
van Staalduinen J, Baker D, ten Dijke P
and van Dam H: Epithelial-mesenchymal-transition-inducing
transcription factors: New targets for tackling chemoresistance in
cancer? Oncogene. 37:6195–6211. 2018.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Zhao L, Liu S, Che X, Hou K, Ma Y, Li C,
Wen T, Fan Y, Hu X, Liu Y and Qu X: Bufalin inhibits TGF-β-induced
epithelial-to-mesenchymal transition and migration in human lung
cancer A549 cells by downregulating TGF-β receptors. Int J Mol Med.
36:645–652. 2015.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Laube G and Bernstein HG: Agmatine:
Multifunctional arginine metabolite and magic bullet in clinical
neuroscience? Biochem J. 474:2619–2640. 2017.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Molderings GJ, Kribben B, Heinen A,
Schroder D, Brüss M and Göthert M: Intestinal tumor and agmatine
(decarboxylated arginine): Low content in colon carcinoma tissue
specimens and inhibitory effect on tumor cell proliferation in
vitro. Cancer. 101:858–868. 2004.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Wolf C, Brüss M, Hänisch B, Göthert M, von
Kügelgen I and Molderings GJ: Molecular basis for the
antiproliferative effect of agmatine in tumor cells of colonic,
hepatic, and neuronal origin. Mol Pharmacol. 71:276–283.
2007.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Haenisch B, Bönisch H, Cichon S, Allam JP,
Novak N and Molderings GJ: Effects of exogenous agmatine in human
leukemia HMC-1 and HL-60 cells on proliferation, polyamine
metabolism and cell cycle. Leuk Res. 35:1248–1253. 2011.PubMed/NCBI View Article : Google Scholar
|
